Literature DB >> 27045052

Beware the yellow slimming pill: fatal 2,4-dinitrophenol overdose.

Alexander Holborow1, Richard M Purnell2, Jenny Frederina Wong3.   

Abstract

An industrial chemical, 2,4-dinitrophenol (DNP), has found use as a weight loss drug. It is extremely toxic in overdose and has a narrow therapeutic window with significant interindividual variability in metabolism. The rise in internet-based sales and distribution of this drug has seen an increased incidence of both accidental and intentional overdose presenting to emergency departments across the UK. No antidote currently exists and overdose is often fatal despite management based on current recommendations. We report a case of intentional overdose of DNP in a young man and discuss the current treatment guidelines. The case highlights the need for an increased awareness among frontline medical staff of the effects of DNP poisoning and questions the need for a more aggressive approach in the management of acute toxicity. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27045052      PMCID: PMC4840695          DOI: 10.1136/bcr-2016-214689

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Weight loss and 2,4-dinitrophenol poisoning.

Authors:  A Tewari; T Ali; A Ali; J O'Donnell; A O'Donnell; M S Butt
Journal:  Br J Anaesth       Date:  2009-04       Impact factor: 9.166

2.  Increasing frequency of severe clinical toxicity after use of 2,4-dinitrophenol in the UK: a report from the National Poisons Information Service.

Authors:  Ashraf Kamour; Nathan George; David Gwynnette; Gillian Cooper; David Lupton; Michael Eddleston; John Paul Thompson; John Allister Vale; Harry Krishna Ruben Thanacoody; Simon Hill; Simon Hugh Lynton Thomas
Journal:  Emerg Med J       Date:  2014-06-23       Impact factor: 2.740

3.  Surviving a life-threatening 2,4-DNP intoxication: 'Almost dying to be thin'.

Authors:  A van Veenendaal; A Baten; P Pickkers
Journal:  Neth J Med       Date:  2011-03       Impact factor: 1.422

Review 4.  2,4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death.

Authors:  Johann Grundlingh; Paul I Dargan; Marwa El-Zanfaly; David M Wood
Journal:  J Med Toxicol       Date:  2011-09

5.  Clinical features and treatment in patients with acute 2,4-dinitrophenol poisoning.

Authors:  Yuan-qiang Lu; Jiu-kun Jiang; Wei-dong Huang
Journal:  J Zhejiang Univ Sci B       Date:  2011-03       Impact factor: 3.066

6.  Deliberate poisoning with dinitrophenol (DNP): an unlicensed weight loss pill.

Authors:  James Bartlett; Michael Brunner; Katie Gough
Journal:  Emerg Med J       Date:  2010-02       Impact factor: 2.740

7.  'Fatal 2,4-dinitrophenol poisoning... coming to a hospital near you'.

Authors:  Claas Siegmueller; Raghunanda Narasimhaiah
Journal:  Emerg Med J       Date:  2010-05-29       Impact factor: 2.740

Review 8.  Toxicity of weight loss agents.

Authors:  May Yen; Michele Burns Ewald
Journal:  J Med Toxicol       Date:  2012-06

Review 9.  Dantrolene--a review of its pharmacology, therapeutic use and new developments.

Authors:  T Krause; M U Gerbershagen; M Fiege; R Weisshorn; F Wappler
Journal:  Anaesthesia       Date:  2004-04       Impact factor: 6.955

  9 in total
  7 in total

1.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

2.  Dantrolene is not the answer to 2,4-dinitrophenol poisoning: more heated debate.

Authors:  Jason Van Schoor; Esha Khanderia; Andrew Thorniley
Journal:  BMJ Case Rep       Date:  2018-12-19

3.  Dinitrophenol (DNP) Fatality Associated with a Falsely Elevated Salicylate Level: a Case Report with Verification of Laboratory Cross Reactivity.

Authors:  Kathryn T Kopec; Caroline Freiermuth; Susan Maynard; Michael Beuhler
Journal:  J Med Toxicol       Date:  2018-07-26

4.  Physiologically-based pharmacokinetic model for 2,4-dinitrophenol.

Authors:  Lyndsey F Meyer; Pooja M Rajadhyaksha; Dhaval K Shah
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-01-28       Impact factor: 2.745

Review 5.  Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a Review.

Authors:  Alex K Bonnecaze; Thomas O'Connor; Cynthia A Burns
Journal:  J Gen Intern Med       Date:  2021-05-04       Impact factor: 6.473

6.  Would You Use It With a Seal of Approval? Important Attributes of 2,4-Dinitrophenol (2,4-DNP) as a Hypothetical Pharmaceutical Product.

Authors:  Emma E Bleasdale; Sam N Thrower; Andrea Petróczi
Journal:  Front Psychiatry       Date:  2018-04-20       Impact factor: 4.157

Review 7.  Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases.

Authors:  Stéphane Demine; Patricia Renard; Thierry Arnould
Journal:  Cells       Date:  2019-07-30       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.